Skip to content

IEMbase 0149: PNP-related purine nucleoside phosphorylase deficiency

Scope

Field Value
IEMbase ID 149
Nosology 16.2.09.01
Gene PNP
External IDs OMIM:613179; OMIM:164050; ORPHA:760
Generated mapping UNMAPPED
Candidate DisMech targets No valid PNP deficiency target found; IKBKG/IMD33 candidate is false
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents this as PNP-related purine nucleoside phosphorylase deficiency, with alternate label T-cell immunodeficiency and abbreviation PNP. Treatability is marked yes.

The biochemical rows include decreased red-cell purine nucleoside phosphorylase activity, increased plasma and urinary deoxyguanosine, increased plasma and urinary deoxyinosine, and decreased plasma and urinary uric acid. Clinical rows include T-cell immunodeficiency, recurrent infections, decreased CD4-positive cells, developmental delay, spastic diplegia, and tetraparesis.

DisMech phenotype coverage

No local PNP/purine nucleoside phosphorylase deficiency entry was found. The generated best candidate, IKBKG_Ectodermal_Dysplasia_with_Immunodeficiency.yaml via an IMD33 label, is not valid: IKBKG-related immunodeficiency is an NF-kB signaling disorder, not a purine nucleoside phosphorylase enzyme deficiency.

Mentions of PNPT1/PNPase or thiopurine metabolism elsewhere in the KB do not provide disease-level coverage for PNP deficiency.

Concordance and completeness

Judgement: true unmapped local disease gap.

The IEMbase record has a distinctive purine salvage and T-cell immunodeficiency signature: low PNP enzyme activity, deoxyguanosine/deoxyinosine accumulation, low uric acid, recurrent infections, T-cell deficiency, and neurologic motor involvement. Current DisMech has adjacent purine-metabolism and immunodeficiency content but not this disease.

Curation actions

  • Keep this record unmapped.
  • Reject the IKBKG/IMD33 candidate as an immunodeficiency-label false positive.
  • Future curation should add PNP deficiency with purine nucleoside metabolite accumulation, low uric acid, T-cell immunodeficiency, recurrent infections, developmental delay, spastic diplegia, and tetraparesis.